{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:23:11Z","timestamp":1790716991589,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Australian National Health and Medical Research Foundation","award":["APP1108050"],"award-info":[{"award-number":["APP1108050"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartlungcirc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.hlc.2019.05.183","type":"journal-article","created":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T18:38:05Z","timestamp":1560364685000},"page":"742-747","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Early Outcomes of Surgery for Carcinoid Heart Disease"],"prefix":"10.1016","volume":"29","author":[{"given":"Matthew S.","family":"Yong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash","family":"Ludhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Michael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Hofman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney J.","family":"Hicks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Larobina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hlc.2019.05.183_bib0005","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1634\/theoncologist.10-2-123","article-title":"Metastatic carcinoid tumors: a clinical review","volume":"10","author":"Zuetenhorst","year":"2005","journal-title":"Oncologist"},{"key":"10.1016\/j.hlc.2019.05.183_bib0010","doi-asserted-by":"crossref","first-page":"T135","DOI":"10.1530\/ERC-16-0370","article-title":"Women in cancer thematic review: systemic therapies in neuroendocrine tumors and novel approaches toward personalized medicine","volume":"23","author":"Pavel","year":"2016","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.hlc.2019.05.183_bib0015","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1200\/JCO.2009.22.8510","article-title":"Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group","volume":"27","author":"Rinke","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hlc.2019.05.183_bib0020","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1530\/ERC-15-0490","article-title":"Anti-tumour effects of lanreotide for pancreatic and intestinal neuroendocrine tumours: the CLARINET open-label extension study","volume":"23","author":"Caplin","year":"2016","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.hlc.2019.05.183_bib0025","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa1607427","article-title":"Phase 3 trial of (177)lu-dotatate for midgut neuroendocrine tumors","volume":"376","author":"Strosberg","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2019.05.183_bib0030","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000443167","article-title":"ENETS consensus guidelines update for the management of distant metastatic disease of intestinal, pancreatic, bronchial neuroendocrine neoplasms (NEN) and NEN of unknown primary site","volume":"103","author":"Pavel","year":"2016","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.hlc.2019.05.183_bib0035","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000381930","article-title":"carcinoid heart disease: from pathophysiology to treatment\u2014\u2019Something in the Way It Moves\u2019","volume":"101","author":"Grozinsky-Glasberg","year":"2015","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.hlc.2019.05.183_bib0040","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/0735-1097(94)00374-Y","article-title":"Outcome of cardiac surgery for carcinoid heart disease","volume":"25","author":"Connolly","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2019.05.183_bib0045","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1210\/jc.2015-3295","article-title":"Effect of valvular surgery in carcinoid heart disease: an observational cohort study","volume":"101","author":"Edwards","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.hlc.2019.05.183_bib0050","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1016\/j.jacc.2015.09.014","article-title":"Early and late outcomes of surgical treatment in carcinoid heart disease","volume":"66","author":"Connolly","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2019.05.183_bib0055","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1053\/j.ajkd.2005.02.009","article-title":"Acute renal failure after cardiac surgery for carcinoid heart disease: incidence, risk factors, and prognosis","volume":"45","author":"Regner","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.hlc.2019.05.183_bib0060","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000446213","article-title":"Optimized outcomes using a standardized approach for treatment of patients with carcinoid heart disease","volume":"104","author":"Silaschi","year":"2017","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.hlc.2019.05.183_bib0065","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jtcvs.2018.09.025","article-title":"Improving outcome of valve replacement for carcinoid heart disease","volume":"158","author":"Nguyen","year":"2019","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.hlc.2019.05.183_bib0070","first-page":"71","article-title":"Changing paradigms with molecular imaging of neuroendocrine tumors","volume":"14","author":"Hofman","year":"2012","journal-title":"Discov Med"},{"key":"10.1016\/j.hlc.2019.05.183_bib0075","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1213\/01.ane.0000284704.57806.0b","article-title":"Intraoperative management of patients with carcinoid heart disease having valvular surgery: a review of one hundred consecutive cases","volume":"105","author":"Weingarten","year":"2007","journal-title":"Anesth Analg"},{"key":"10.1016\/j.hlc.2019.05.183_bib0080","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000335600","article-title":"ENETS 2011 consensus guidelines for the management of patients with digestive neuroendocrine tumors: an update","volume":"95","author":"Salazar","year":"2012","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.hlc.2019.05.183_bib0085","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1007\/s00259-014-2788-5","article-title":"Assessment of predictors of response and long-term survival of patients with neuroendocrine tumour treated with peptide receptor chemoradionuclide therapy (PRCRT)","volume":"41","author":"Kong","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.hlc.2019.05.183_bib0090","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.jacc.2007.12.036","article-title":"Early and late results of valvular surgery for carcinoid heart disease","volume":"51","author":"Castillo","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2019.05.183_bib0095","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0002-9149(99)80586-4","article-title":"Predictors of outcome of tricuspid valve replacement in carcinoid heart disease","volume":"75","author":"Robiolio","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hlc.2019.05.183_bib0100","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ejcts.2010.10.035","article-title":"Outcomes, risks and complications of cardiac surgery for carcinoid heart disease","volume":"40","author":"Bhattacharyya","year":"2011","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.hlc.2019.05.183_bib0105","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1093\/ejcts\/ezr227","article-title":"Carcinoid heart disease: outcomes after surgical valve replacement","volume":"41","author":"Mokhles","year":"2012","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.hlc.2019.05.183_bib0110","doi-asserted-by":"crossref","first-page":"I51","DOI":"10.1161\/01.cir.0000032884.55215.87","article-title":"Carcinoid heart disease: impact of pulmonary valve replacement in right ventricular function and remodeling","volume":"106","author":"Connolly","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2019.05.183_bib0115","first-page":"349","article-title":"Valve replacement in patients with carcinoid heart disease: choosing the right valve at the right time","volume":"25","author":"Korach","year":"2016","journal-title":"J Heart Valve Dis"},{"key":"10.1016\/j.hlc.2019.05.183_bib0120","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13019-015-0238-5","article-title":"Failing stentless bioprostheses in patients with carcinoid heart valve disease","volume":"10","author":"Schaefer","year":"2015","journal-title":"J Cardiothorac Surg"}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950619306067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950619306067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T18:01:28Z","timestamp":1761415288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1443950619306067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S1443950619306067"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2019.05.183","relation":{},"ISSN":["1443-9506"],"issn-type":[{"value":"1443-9506","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early Outcomes of Surgery for Carcinoid Heart Disease","name":"articletitle","label":"Article Title"},{"value":"Heart, Lung and Circulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hlc.2019.05.183","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V. on behalf of Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ).","name":"copyright","label":"Copyright"}]}}